High doses of statins increase osteoporosis risk, shows study in animals
An animal experiment demonstrates what big data analysis previously indicated: high doses of statins likely increase osteoporosis risk.
Mindfully Curated
An animal experiment demonstrates what big data analysis previously indicated: high doses of statins likely increase osteoporosis risk.
People with chronic epilepsy often experience impaired memory. Researchers have now found a mechanism in mice that could explain these deficits.
The growth of Block’s core businesses should be a positive sign for long-term investors.
Here are three businesses that thrive during economic uncertainty.
The market is underrating the long-term trajectory of its cloud business.
This cybersecurity company is showcasing its pricing power.
Despite recent layoffs, Meta may still need to make more cuts to get its expenses under control.
This mistake could cost you hundreds of thousands of dollars.
Which e-commerce services provider is a better turnaround play?
These dividend stocks give their investors an extra special payment each year.
The business is excelling, and the stock is cheap. What’s not to like?
The central bank just raised its rate-hike forecast for 2023. Here’s how investors should think about it.
The two-sided payments enterprise has seen shares drop 61% this year.
There are only three things you have to do.
You can attribute Berkshire Hathaway’s growth to its massive cash pile of “other people’s money.”
This adtech company remains a risky investment.
Working as a retiree might seem like a good idea, but it could have unwanted financial consequences.
Recession fears and high interest rates can’t keep these profitable growth stars down.
I made quite a few investments in 2022, but here’s the one I’m most optimistic about.
There are some excellent bargains in the market — and not just in growth stocks.